Company intelligence / Profile preview

CapTech

Tianjin, Tianjin, China

Ownership: Private
Development stage: Other

Overview

Captech (Tianjin) Medical Devices is a medical technology company specializing in the development and manufacturing of interventional cardiology products. The company's primary focus is on the design and production of coronary stent systems and balloon dilatation catheters used in percutaneous coronary intervention (PCI) procedures. Based in China, Captech provides high-quality cardiovascular solutions aimed at treating coronary artery disease and improving patient outcomes in vascular surgery. Their product portfolio includes both bare-metal and drug-eluting stent technologies designed for precision and biocompatibility.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on CapTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CapTech.

Explore the full profile